Breast augmentation poses various risks, including:

  • Scar tissue that distorts the shape of the breast implant (capsular contracture)
  • Breast pain
  • Infection
  • Changes in nipple and breast sensation, usually temporary
  • Implant leakage or rupture

Correcting any of these complications might require additional surgery, either to remove or replace the implants.

The Food and Drug Administration (FDA) has identified a possible association between breast implants and the development of anaplastic large cell lymphoma (ALCL), a rare cancer of the immune system. The FDA believes that women with breast implants may have a very low but increased risk of developing ALCL. However, further research is needed to fully understand the relationship between ALCL and breast implants.

July 16, 2015